On 24 September, uniQure announced positive topline results from its pivotal Phase I/II studies (HD-GENE-TRX1, HD-GENE-TRX2) ...

Pi Health is to deliver outsourced clinical research services in a GSK oncology study to enhance the efficiency and speed of ...

Bayer vice president Luiz Barberini explains how the German giant’s cooperation with suppliers fosters long-term trial ...

As China's biotech sector continues to buzz with innovation, the country is rapidly integrating into the global clinical ...

MediciNova has completed full patient enrolment in the COMBAT-ALS Phase IIb/III clinical trial of MN-166 (ibudilast) as a ...

In a pair of Phase III trials, J&J and Protagonists' icotrokinra beat BMS' Sotyktu on every skin-clearness measure.

Datavant has partnered with life sciences commercialisation firm Indegene to enhance recruitment of subjects for clinical ...

AstraZeneca’s Saphnelo (SC) administration has shown a decrease in disease activity in individuals with systemic lupus ...

Nektar Therapeutics has presented data of its atopic dermatitis (AD) candidate rezpeg (rezpegaldesleukin), which sent the ...

PepGen’s stock has risen by over 120% after its investigational myotonic DM1 candidate reported the highest mean splicing correction in a Phase I trial.

REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence with clinical study data within a single ...

The main concerns about tariffs that businesses have are higher input costs and uncertainty in long-term planning.